Company Overview
Snapshot
Founded in January 2023 by Roy Birman, Pharmmies operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on the development of innovative pharmaceutical gummies.
Business overview
Pharmmies specializes in the development of pharmaceutical gummies that incorporate precise dosages of Active Pharmaceutical Ingredients. The company's core technology involves infusing these active compounds into gummy formulations, targeting the drug delivery market within the Health Tech & Life Sciences sector. Pharmmies serves the pharmaceuticals industry with products like Clariva™, IBUMMIES™, ACETAMMIES™, AllerGum™, and Tivaro ™, operating on a B2B2C business model.
Log in to access full profile ›Company Intelligence Q&A
- When was Pharmmies founded?
- Pharmmies was founded in January 2023.
- Who is the founder of Pharmmies?
- Roy Birman is the Founder & CEO of Pharmmies.
- What is Pharmmies' primary business model?
- Pharmmies operates on a B2B2C business model, focusing on delivering pharmaceutical gummies to the market.
- What products does Pharmmies offer?
- Pharmmies offers a range of products including Clariva™, IBUMMIES™, ACETAMMIES™, AllerGum™, and Tivaro ™, which are pharmaceutical gummies with precise dosages.
- What is Pharmmies' current product development stage?
- Pharmmies' products are currently in the Research and Development (R&D) stage, focusing on infusing active pharmaceutical ingredients into gummy formulations.